These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 181839)

  • 1. Effects of granulocyte neutral proteases on complement components.
    Johnson U; Ohlsson K; Olsson I
    Scand J Immunol; 1976; 5(4):421-6. PubMed ID: 181839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of granulocyte elastase in lethal canine endotoxin shock.
    Aasen AO; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):683-90. PubMed ID: 352893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory processes.
    Ohlsson K; Olsson I
    Scand J Haematol; 1977 Aug; 19(2):145-52. PubMed ID: 197589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
    Venge P; Olsson I
    J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte collagenase and elastase and the plasma protease inhibitors in human pus.
    Delshammar M; Ohlsson K
    Surgery; 1978 Mar; 83(3):323-7. PubMed ID: 204072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the reactions of neutral granulocyte proteases with the major plasma protease inhibitors and with antiplasmin.
    Ohlsson K; Collen D
    Scand J Clin Lab Invest; 1977 Jun; 37(4):345-50. PubMed ID: 210494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutral proteases of human granulocytes. IV. Interaction between human granulocyte collagenase and plasma protease inhibitors.
    Ohlsson K; Olsson I
    J Lab Clin Med; 1977 Feb; 89(2):269-77. PubMed ID: 64576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagenase and elastase released during peritonitis are complexed by plasma protease inhibitors.
    Ohlsson K
    Surgery; 1976 Jun; 79(6):652-7. PubMed ID: 179159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.
    Ohlsson K; Tegner H
    Scand J Clin Lab Invest; 1976 Sep; 36(5):437-45. PubMed ID: 185683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration and semiquantitative determination of complexes between various proteases and human alpha2-macroglobulin.
    Ohlsson K; Skude G
    Clin Chim Acta; 1976 Jan; 66(1):1-7. PubMed ID: 177230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of functional of alpha 1-proteinase inhibitor in the promotion of C3-cleavage by granulocyte-neutral proteases in pleural empyema.
    Suter S; Berger D; Despont JP; Waldvogel F
    J Infect Dis; 1984 Jun; 149(6):935-41. PubMed ID: 6203992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanial protein kinases phosphorylate components of the complement system.
    Hermoso T; Fishelson Z; Becker SI; Hirschberg K; Jaffe CL
    EMBO J; 1991 Dec; 10(13):4061-7. PubMed ID: 1756717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG; Liebowitch J; Amos N; Peters DK
    J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.